MedTrace Logo

Randomized Controlled Effectiveness Trial of VA S.A.V.E.

NCT06470867 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 710

Last updated 2025-10-27

No results posted yet for this study

Summary

Veterans are most likely to disclose suicidal thoughts to their close supports such as family and friends. These loved ones are, in turn, very interested in learning how to help a Veteran in need. Close supports are uniquely poised to provide a meaningful contribution to suicide prevention, if they can learn how to effectively promote Veterans' connection to care. VA S.A.V.E. (Signs; Ask; Validate; Encourage) is a suicide prevention gatekeeper training specifically tailored to the Veteran community that teaches close supports how to identify signs of suicide risk and how to connect the at-risk person to professional treatment. The primary objective of this study is to evaluate the effectiveness of VA S.A.V.E. and to explore factors impacting its potential widespread implementation.

Conditions

  • Suicide Prevention

Interventions

BEHAVIORAL

VA S.A.V.E.

The intervention is called VA S.A.V.E. It is an online video-based training tailored to veterans and their close supports. It is free, brief (24 minutes), and includes three scripted role plays.

BEHAVIORAL

Control training

An attention control informational video containing information relevant to veterans' mental health but not including elements thought to be "active ingredients" in the intervention.

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Alan R. Teo, MD MS · VA Portland Health Care System, Portland, OR

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-21
Primary Completion
2027-05-21
Completion
2028-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06470867 on ClinicalTrials.gov